In accordance with 42 CFR 431.408, the Indiana Family and Social Services Administration (FSSA) will be holding public hearings on a Section 1115 demonstration waiver that will be submitted to the Centers for Medicare and Medicaid Services (CMS). This submission seeks to further the goals of the Maternal Opioid Misuse Indiana initiative (MOMII) by seeking federal authority to extend postpartum coverage from 60 days to 365 days postpartum for mothers with OUD who initially qualified with income at or below 213% FPL, and maintain continuous eligibility for the mother and baby during the entire postpartum period. These provisions will apply to mothers with OUD who are found eligible and are enrolled as of the date pregnancy ends, even if application is made after the end of pregnancy and eligibility is established retroactively (beginning in the application month or one of the three months prior to the application month). This request is part of Indiana's broader efforts to lower infant mortality and address the drug epidemic. The proposed effective date of the demonstration is July 1, 2021, pending CMS approval.

Hearings will be held as follows:

All information regarding the submission, including the public notice, the waiver, and other documentation regarding the proposal are available for public review at the FSSA, Office of Medicaid Policy and Planning, 402 West Washington Street, Room W374, Indianapolis, Indiana 46204. These documents are also available to be viewed online at https://www.in.gov/fssa/5537.htm.

Written comments regarding the waiver amendment will be accepted through 5:00 p.m. on September 11, 2020, and may be sent to the FSSA via email at sara.albertson@fssa.in.gov or via mail at:

Jennifer Sullivan, M.D., MPH

Secretary

Family and Social Services Administration